| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |